ガイドラインに心エコーを生かす

出版社: メジカルビュー社
著者:
発行日: 2020-04-01
分野: 臨床医学:内科  >  循環器一般
ISBN: 9784758319638
電子書籍版: 2020-04-01 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

6,380 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

6,380 円(税込)

商品紹介

今や循環器疾患の診療に「心エコー」「診療ガイドライン」は欠かせないが,臨床では常にガイドライン通りの手順や手法で心エコー図検査が行えるとは限らない。鑑別診断に迷ったときは? 各指標が意味するものとは? 米国や欧州のガイドラインをそのまま適用してよいのか? ガイドライン改訂で何が変わったのか?
ガイドラインをどう解釈し活用していくべきか,本書は各疾患につき関連ガイドラインのポイントと,診断・治療のコツを具体的な症例をもとに解説。どのように臨床に落とし込み・擦り合わせて生かしていくか,そのエッセンスをまとめた。

目次

  • I 計測
     1 左心系の計測
     2 右心系の計測

    II 拡張機能
     1 ベーシック
     2 アドバンス

    III 心筋症
     1 拡張型心筋症
     2 肥大型心筋症
     3 不整脈原性右室心筋症
     4 アミロイドーシス
     5 高血圧性心疾患
     6 ファブリー病
     7 特発性拘束型心筋症
     8 心臓サルコイドーシス
     9 心筋炎
     10 がん治療関連心機能障害
     11 周産期心筋症
     12 アスリートハート
     13 虚血性心筋症

    IV 心膜炎
     1 急性心膜炎
     2 心タンポナーデ
     3 収縮性心膜炎

    V 不整脈
     1 心房細動

    VI 心不全
     1 左室駆出率が保たれた心不全
     2 心臓再同期療法
     3 植込み型人工心臓の管理

    VII 弁膜症
     1 左室駆出率が保たれた大動脈弁狭窄症
     2 左室駆出率が低下した大動脈弁狭窄症
     3 TAVIが行われた大動脈弁狭窄症
     4 大動脈二尖弁
     5 大動脈弁閉鎖不全症(弁性)
     6 大動脈弁閉鎖不全症(大動脈性)
     7 一次性(器質性)僧帽弁閉鎖不全症
     8 二次性(機能性)僧帽弁閉鎖不全症:左室収縮能低下
     9 左室収縮能低下による機能性僧帽弁閉鎖不全症に対する外科治療
     10 MitraClipが行われた僧帽弁閉鎖不全症
     11 心房性機能性僧帽弁閉鎖不全症
     12 僧帽弁狭窄症
     13 三尖弁閉鎖不全症
     14 人工弁機能不全
     15 感染性心内膜炎

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 計測

P.8 掲載の参考文献
1) Lang RM, et al : Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J AM Soc Echocardiogr 28 : 1-39, 2015.
P.16 掲載の参考文献
1) Lang RM, et al : Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 : 1-39 e14, 2015.
3) Shimada YJ, et al : Accuracy of right ventricular volumes and function determined by three-dimensional echocardiography in comparison with magnetic resonance imaging : a meta-analysis study. J Am Soc Echocardiogr 23 : 943-953, 2010.
4) Fukuda Y, et al : Utility of combining assessment of right ventricular function and right atrial remodeling as a prognostic factor for patients with pulmonary hypertension. Int J Cardiovasc Imaging 30 : 1269-1277, 2014.
5) Fukuda Y, et al : Utility of right ventricular free wall speckle-tracking strain for evaluation of right ventricular performance in patients with pulmonary hypertension. J Am Soc Echocardiogr 24 : 1101-1108, 2011.
6) Motoji Y, et al : Efficacy of right ventricular free-wall longitudinal speckle-tracking strain for predicting long-term outcome in patients with pulmonary hypertension. Circ J 77 : 756-763, 2013.
8) Sano H, et al : Right ventricular function and right-heart echocardiographic response to therapy predict long-term outcome in patients with pulmonary hypertension. Can J Cardiol 31 : 529-536, 2015.

II 拡張機能

P.22 掲載の参考文献
1) Nagueh SF, Smiseth OA, Appleton CP, et al : Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography : An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29 (4) : 277-314, 2016.
2) 日本心エコー図学会ガイドライン作成委員会 訳 : 心エコーによる左室拡張機能評価のための勧告 : アメリカ心エコー図学会 (American Society of Echocardiography) およびヨーロッパ心血管画像学会 (European Association of Cardiovascular Imaging) による改訂. 日本心エコー図学会, 2016. (http://www.jse.gr.jp/contents/guideline/data/ASE-EACVIguideline%EF%BC%86base.pdf).
P.31 掲載の参考文献
1) Nagueh SF, et al : Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography : An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 29 : 277-314, 2016.
2) Sugiura E, et al : Successful peritoneal dialysis for the treatment of inotrope-dependent end-stage heart failure. Int Heart J 60 : 1211-1218, 2019.

III 心筋症

P.38 掲載の参考文献
1) 日本循環器学会/日本心不全学会合同ガイドライン : 心筋症診療ガイドライン (2018年改訂版), 2018. (http://www.j-circ.or.jp/guideline/pdf/JCS2018_tsutsui_kitaoka.pdf)
2) Cerqueira MD, et al : Rarity of preclinical alcoholic cardiomyopathy in chronic alcoholics less than 40 years of age. Am J Cardiol 67 : 183-187, 1991.
3) Matsumori A, et al : Epidemiologic and clinical characteristics of cardiomyopathies in Japan : results from nationwide surveys. Circ J 66 : 323-336, 2002.
4) Zamorano JL, et al : 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines : The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37 : 2768-2801, 2016.
5) Chimura M, et al : Ratio of pulmonary artery diameter to ascending aortic diameter and severity of heart failure. J Heart Lung Transplant 37 : 1341-1350, 2018.
P.47 掲載の参考文献
1) 日本循環器学会/日本心不全学会合同ガイドライン : 心筋症診療ガイドライン (2018年改訂版), (http://www.j-circ.or.jp/guideline/pdf/JCS2018_tsutsui_kitaoka.pdf) (2019年11月閲覧).
2) Elliott PM, et al : 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy : the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35 : 2733-2779, 2014.
3) Gersh BJ, et al : 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 58 : e212-260, 2011.
P.56 掲載の参考文献
4) Saguner AM, et al : Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ Cardiovasc Imaging 7 : 230-239, 2014.
5) Cho GY, et al : Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am Coll Cardiol 54 : 618-624, 2009.
6) Longobardo L, et al : Role of Two-Dimensional Speckle-Tracking Echocardiography Strain in the Assessment of Right Ventricular Systolic Function and Comparison with Conventional Parameters. J Am Soc Echocardiogr 30 : 937-946 e6, 2017.
7) Teske AJ, et al : Early detection of regional functional abnormalities in asymptomatic ARVD/C gene carriers. J Am Soc Echocardiogr 25 : 997-1006, 2012.
8) Turrini P, et al : Dispersion of ventricular depolarization-repolarization : a noninvasive marker for risk stratification in arrhythmogenic right ventricular cardiomyopathy. Circulation 103 : 3075-3080, 2001.
9) Sarvari SI, et al : Right ventricular mechanical dispersion is related to malignant arrhythmias : a study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J 32 : 1089-1096, 2011.
10) Leren IS, et al : Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC. JACC Cardiovasc Imaging 10 : 503-513, 2017.
11) Gallo P, et al : Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Hum Pathol 23 : 948-952, 1992.
12) Mast TP, et al : Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome. J Am Soc Echocardiogr 28 : 1103-1113 e9, 2015.
13) Corrado D, et al : Arrhythmogenic right ventricular cardiomyopathy : evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J [Epub ahead of print], 2019.
14) Saberniak J, et al : Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia. Eur Heart J Cardiovasc Imaging 18 : 62-69, 2017.
15) D'Ascenzi F, et al : Diagnostic Differentiation Between Arrhythmogenic Cardiomyopathy and Athlete's Heart by Using Imaging. JACC Cardiovasc Imaging 11 : 1327-1339, 2018.
P.64 掲載の参考文献
1) Koyama J, et al : Role of echocardiography in assessing cardiac amyloidoses : a systematic review. J Echocardiogr 17 : 64-75, 2019.
2) Koyama J, et al : Echocardiographic assessment of cardiac amyloidoses. Circ J 79 : 721-734, 2015.
P.71 掲載の参考文献
2) Elliott PM, et al : 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy : the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 35 : 2733-2779, 2014.
4) 日本高血圧学会高血圧治療ガイドライン2019作成委員会 : 高血圧治療ガイドライン 2019, ライフサイエンス出版, 2019.
P.77 掲載の参考文献
1) ライソゾーム病 (ファブリー病を含む) に関する調査研究班班 編 : ファブリー病診療ガイドライン 2019.
2) Nakao S, et al : An atypical variant of Fabry's desease in men with left ventricular hypertrophy. N Engl J Med 333 : 288-293, 1995.
4) Monserrat L, et al : Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 50 : 2399-2403, 2007.
P.83 掲載の参考文献
P.91 掲載の参考文献
1) 日本循環器学会ほか : 2016年版 心臓サルコイドーシスの診療ガイドライン, 2016. (http://www.j-circ.or.jp/guideline/pdf/JCS2016_terasaki_h.pdf)
2) Terasaki F, et al : Japanese Circulation Society Joint Working Group. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis Digest Version-. Circ J 83 : 2329-2388, 2019.
3) 日本サルコイドーシス/肉芽種性疾患学会 : サルコイドーシス診療の手引き 2018 (Last Update : 2019年10月16日). (http://jssog.com/www/top/kenkai20118.html)
P.99 掲載の参考文献
P.103 掲載の参考文献
1) Plana JC, et al : Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy : A report from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 27 : 911-939, 2014.
2) Zamorano JL, et al : 2016 esc position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines : The task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (esc). Eur Heart J 37 : 2768-2801, 2016.
3) Lang RM, et al : Recommendations for chamber quantification : A report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr 18 : 1440-1463, 2005.
4) Lang RM, et al : Recommendations for cardiac chamber quantification by echocardiography in adults : An update from the american society of echocardiography and the european association of cardiovascular imaging. J Am Soc Echocardiogr 28 : 1-39 e14, 2015.
P.110 掲載の参考文献
1) 日本循環器学会/日本産科婦人科学会合同ガイドライン : 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン (2018年改訂版), 2019. (http://www.j-circ.or.jp/guideline/pdf/JCS2018_akagi_ikeda.pdf)
2) 厚生労働省科学研究難治性疾患政策研究事業「周産期心筋症ガイドライン作成」班「特発性心筋症に関する調査研究」班 : 周産期心筋症診療の手引き, 中外医学社, 2019.
3) Kamiya CA, et al : Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ J 75 : 1975-1981, 2011.
4) Isogai T, Kamiya CA : Worldwide Incidence of Peripartum Cardiomyopathy and Overall Maternal Mortality. Int Heart J 60 : 1-7, 2019.
5) Bello N, et al : The relationship between Preeclampsia and Peripartum Cardiomyopathy : a Systematic Review and Meta-Analysis. J of Am Coll Cardiol 62 : 1715-1723, 2013.
11) Hilfiker-Kleiner D, et al : Bromocriptine for the treatment of peripartum cardiomyopathy : a multicentre randomized study. Eur Heart J 38 : 2674-2679, 2017.
P.119 掲載の参考文献
1) Maron BJ, et al : Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities : Task Force 3 : Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis : A Scientific Statement From the A merican Heart Association and American College of Cardiology. Circulation 132 : e273-280, 2015.
2) Pelliccia A, et al : European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement : recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart. Eur Heart J 39 : 1949-1969, 2018.
P.125 掲載の参考文献
1) 日本循環器学会ほか : 心筋症診療ガイドライン (2018年改訂版). (http://www.j-circ.or.jp/guideline/pdf/JCS2018_tsutsui_kitaoka.pdf)
2) 日本循環器学会ほか : 慢性冠動脈疾患診断ガイドライン (2018年改訂版). (http://www.j-circ.or.jp/guideline/pdf/JCS2018_yamagishi_tamaki.pdf)
3) Suzuki K, et al : Practical guidance for the implementation of stress echocardiography. J Echocardiogr 16 : 105-129, 2018.
4) Gorcsan J 3rd : Echocardiographic strain imaging for myocardial viability : an impovement over visual assessment? Circulation 112 : 3820-3822, 2005.

IV 心膜炎

P.131 掲載の参考文献
2) Klein AL, et al : American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease : endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 26 : 965-1012, e1015, 2013.
P.137 掲載の参考文献
1) Klein AL, et al : American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease : endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 26 : 965-1012, e15, 2013.
3) Rezq A, et al : Incidence, management, and outcomes of cardiac tamponade during transcatheter aortic valve implantation : a single-center study. JACC Cardiovasc Interv 5 : 1264-1272, 2012.
P.146 掲載の参考文献
1) Akasaka T, et al : Phasic Coronary Flow Characteristics in Patients with Constrictive Pericarditis : Comparison with Restrictive Rardiomyopathy. Circulation 96 : 1874-1881, 1997.
2) Gregory MA, et al : Myocardial Ischaemia in Constrictive Pericarditis : A Morphometric and Electron Microscopical Study. Br J Exp Pathol 65 : 365-376, 1984.
3) Klein AL, et al : American Society of Echocardiography Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease : Endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 26 : 965-1012, 2013.

V 不整脈

P.154 掲載の参考文献
1) Donal E, et al : EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. European Heart Journal-Cardiovascular Imaging 17 : 355-383, 2016.
2) Fuster V, et al : ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 : e257-354, 2006.
3) Tsang TS, et al : Left atrial volume : important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo clin Proc 76 : 467-475, 2001.
4) Lang RM, et al : Recommendations for cardiac chamber quantification by echocardiography in adults : an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 28 : 1-39 e14, 2015.
5) Miyasaka Y, et al : Left Atrial Volume by Real-Time Three-Dimensional Echocardiography : Validation by 64-Slice Multidetector Computed Tomography. J Am Soc Echocardiogr 24 : 680-686, 2011.
6) Perez de Isla L, et al : Quantification of left atrial volumes using three-dimensional wall motion tracking echocardiographic technology : comparison with cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging 15 : 793-799, 2014.
7) Cameli M, et al : Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol 111 : 595-601, 2013.
8) Donal E, et al : The left atrial appendage, a small, blind-ended structure : a review of its echocardiographic evaluation and its clinical role. Chest 128 : 1853-1862, 2005.

VI 心不全

P.159 掲載の参考文献
1) 日本循環器学会/日本心不全学会合同ガイドライン : 急性・慢性心不全診療ガイドライン (2017年改訂版), 2018. (http://www.j-circ.or.jp/guideline/pdf/JCS2017_tsutsui_h.pdf)
P.167 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会合同ガイドライン : 不整脈非薬物治療ガイドライン (2018年改訂版) (http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf)
3) Beela AS, et al : Assessment of mechanical dyssynchrony can improve the prognostic value of guideline-based patient selection for cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging 20 : 66-74, 2019.
4) Brugada J, et al : Contractility sensor-guided optimization of cardiac resynchronization therapy : results from the RESPOND-CRT trial. Eur Heart J 38 : 730-738, 2017.
P.171 掲載の参考文献
1) 日本循環器学会/日本心臓血管外科学会合同ガイドライン (2011-2012年度合同研究班報告) : 重症心不全に対する植込型補助人工心臓治療ガイドライン. (http://www.j-circ.or.jp/guideline/pdf/JCS2013_kyo_h.pdf)
2) Stainback RF, et al : Echocardiography in the Management of Patients with Left Ventricular Assist Devices : Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr 28 : 853-909, 2015.

VII 弁膜症

P.176 掲載の参考文献
2) Maes F, et al : Natural History of Paradoxical Low-Gradient Severe Aortic Stenosis. Circ Cardiovasc Imaging 7 : 714-722, 2014.
3) Saeed S, et al : The impact of aortic valve replacement on survival in patients with normal flow low gradient severe aortic stenosis : a propensity-matched comparison. Eur Heart J Cardiovasc Img 20 : 1094-1101, 2019.
4) Zusman O, et al : Intervention Versus Observation in Symptomatic Patients With Normal Flow Low Gradient Severe Aortic Stenosis. J Am Coll Cardiol Img 11 : 1225-1232, 2018.
P.180 掲載の参考文献
1) Nishimura RA, et al : 2014 AHA/ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 : e57-185, 2014.
P.187 掲載の参考文献
P.192 掲載の参考文献
2) Nishimura RA, et al : 2014 AHA/ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 : e521-643, 2014.
3) Borger MA, et al : The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy : Executive summary. J Thorac Cardiovasc Surg 156 : 473-480, 2018.
4) Borger MA, et al : Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg 128 : 677-683, 2004.
5) Yasuda H, et al : Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve : comparison with tricuspid aortic valve. Circulation 108 (suppl II) : 291-294, 2003.
7) Takagi H, Hari Y, et al : Meta-analysis of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic valves. J Cardiol 74 : 40-48, 2019.
P.201 掲載の参考文献
1) Boohwani M, et al : Repair-oriented classification of aortic insufficiency : impact on surgical techniques and clinical outcomes. J Thorac ardiovasc Surg 137 : 286-294, 2009.
2) Nishimura RA, et al : 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 : 57-185, 2014.
5) Schafers H, et al : Cusp height in aortic valves. J Thorac Cardiovasc Surg 146 : 269-274, 2013.
P.209 掲載の参考文献
2) Steven AG, et al : Multimodality Imaging of Diseases of the Thoracic Aorta in Adults : From the American Society of Echocardiography and the European Association of Cardiovascular Imaging Endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 28 : 119-182, 2015.
3) Daimon M, et al : Normal values of echocardiographic parameters in relation to age in a healthy Japarlese population : The JAMP study. Circ J 72 : 1859-1866, 2008.
4) William AZ, et al : Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation-A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular-. J Am Soc Echocardiogr 30 : 303-371, 2017.
P.217 掲載の参考文献
2) Nishimura RA, et al : 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135 : e1159-e1195, 2017.
3) Anyanwu AC, Adams DH : Etiologic classification of degenerative mitral valve disease : Barlow's disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg 19 : 90-96, 2007.
4) Magne J, et al : Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 122 : 33-41, 2010.
5) Utsunomiya H, et al : Exercise-Stress Echocardiography and Effort Intolerance in Asymptomatic/Minimally Symptomatic Patients With Degenerative Mitral Regurgitation Combined Invasive-Noninvasive Hemodynamic Monitoring. Circ Cardiovasc Imaging 11 : e007282, 2018.
P.224 掲載の参考文献
3) Nishimura RA, et al : 2014 AHA/ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 148 : e1-132, 2014.
4) Nishimura RA, et al : 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 135 : e1159-1195, 2017.
5) Bertrand PB, et al : Exercise Dynamics in Secondary Mitral Regurgitation : Pathophysiology and Therapeutic Implications. Circulation 135 : 297-314, 2017.
6) Dulgheru R, et al : Dynamic Ischaemic Mitral Regurgitation and the Role of Stress Echocardiography. J Cardiovasc Echogr 23 : 10-17, 2013.
P.233 掲載の参考文献
1) Nishimura RA, et al : 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease ; A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 70 : 252-289, 2017.
4) Braun J, et al : Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 85 : 430-436, 2008.
5) Crabtree TD, et al : Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg 85 : 1537-1542, 2008.
6) Nagaoka E, Arai H : Surgical strategy for ischemic mitral regurgitation : Indication and limitation. J Jpn Coron Assoc 23 : 121-124, 2017.
7) Lancellotti P, et al : Recommendations for the echocardiographic assessment of native valvular regurgitation : an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14 : 611-644, 2013.
8) Rodriguez F, et al : Importance of mitral valve second-order chordae for left ventricular geometry, wall thicknening mechanics, and global systolic function. Circulation 110 (11 Suppl 1) : II 115-122, 2004.
9) Watanabe T, et al : Influence of procedural differences on mitral valve configuration after surgical repair for functional mitral regurgitation : in which direction should the papillary muscle be relocated? J Cardiothorac Surg 9 : 185, 2014.
10) de Varennes B, et al : Initial results of posterior leaflet extension for severe type IIIb ischemic mitral regurgitation. Circulation 119 : 2837-2843, 2009.
11) Goldstein D, et al : CTSN ; Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Eng J Med 374 : 344-353, 2016.
P.241 掲載の参考文献
2) 日本循環器学会ほか : 弁膜疾患の非薬物治療に関するガイドライン (2012年改訂版), 2012. (http://www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf)
3) Nishimura RA, et al : ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease : executive summary : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 : 2440-2492, 2014.
P.246 掲載の参考文献
1) Abe Y, et al : Prevalence and prognostic significance of functional mitral and tricuspid regurgitation despite preserved left ventricular ejection fraction in atrial fibrillation patients. Circ J 82 : 1451-1458, 2018.
2) Machino-Ohtsuka T, et al : Novel mechanistic insights into atrial functional mitral regurgitation : 3-dimensional echocardiographic study. Circ J 80 : 2240-2248, 2016.
3) Kagiyama N, et al : Insufficient leaflet remodeling in patients with atrial fibrillation : association with the severity of mitral regurgitation. Circ Cardiovasc Imaging 10 : e005451, 2017.
4) Ito K, et al : Mechanism of atrial functional mitral regurgitation in patients with atrial fibrillation : a study using three-dimensional transesophageal echocardiography. J Cardiol 70 : 584-590, 2017.
6) Takahashi Y, et al : Mid-term results of valve repairs for atrial functional mitral and tricuspid regurgitations. Gen Thorac Cardiovasc Surg [Epub ahead of print] 2019.
P.253 掲載の参考文献
1) Iung B, Vahanian A : Epidemiology of acquired valvular heart disease. Can J Cardiol 30 : 962-970, 2014.
2) Abramowitz Y, et al : Mitral annulus calcification. J Am Coll Cardiol 66 : 1934-1941, 2015.
3) Gash AK, et al : Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis. Circulation 67 : 148-154, 1983.
4) Sunamori M, et al : Relationship between left ventricular morphology and postoperative cardiac function following valve replacement for mitral stenosis. J Thorac Cardiovasc Surg 85 : 727-732, 1983.
5) Heller SJ, Carleton RA : Abnormal left ventricular contraction in patients with mitral stenosis. Circulation 42 : 1099-1110, 1970.
6) Liu CP, et al : Reduced left ventricular compliance in human mitral stenosis. Role of reversible internal constraint. Circulation 85 : 1447-1456, 1992.
7) OLESEN KH : The natural history of 271 patients with mitral stenosis under medical treatment. Br Heart J 24 : 349-357, 1962.
8) ROWE JC, et al : The course of mitral stenosis without surgery : ten-and twenty-year perspectives. Ann Intern Med 52 : 741-749, 1960.
9) Mann DL, et al : Braunwalld's Heart Disease : A Textbook of Cardiovascular Medicine, 10th ed, Elsvier Saunders Pblishers, 1469-1479, 2015.
10) Sagie A, et al : Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients : valve area and right heart disease. J Am Coll Cardiol 28 : 472-479, 1996.
11) Nishimura RA, et al : 2014 AHA/ACC guidline for the management of patients with valvular heart disease. J Am Coll Cardiol 63 : e57-185, 2014.
12) Tsang W, et al : Three-dimensional anatomy of the aortic and mitral valves. Valvular heart disease : A Companion to Braunwald's Heart Disease, 4th ed, (Otto CM, Bonow RO eds), Saunders, 14-29, 2013.
13) Baumgartner H, et al : 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38 : 2739-2791, 2017.
14) 日本循環器学会ほか : 弁膜疾患の非薬物治療に関するガイドライン (2012年改訂版), 2012. (http://www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf)
15) Wilkins GT, et al : Percutaneous balloon dilatation of the mitral valve : an analysis of echocardiographic variables related to outcome and the mechanism of dilatation Requests for reprints to Dr Arthur E Weyman, Cardiac Noninvasive. Br Hear J 60 : 299-308, 1988.
16) Akram MR, et al : Non-rheumatic annular mitral stenosis : Prevalence and characteristics. Eur J Echocardiogr 10 : 103, 2009.
P.260 掲載の参考文献
1) Nishimura RA, et al : ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease : Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 : 2440-2492, 2014.
2) Baumgartner H, et al : ESC Scientific Document Group. 2017 ESC/EACTC Guidelines for the management of valvular heart disease. Eur Heart J 38 : 2739-2791, 2017.
3) Zoghbi WA, et al : Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation : A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. JASE 30 : 303-371, 2017.
4) Lancellotti P, et al : Recommendations for the echocardiographic assessment of native valvular regurgitation : an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14 : 611-644, 2013.
5) Lang RM, et al : Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults : An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. JASE 28 : 1-39, 2015.
6) Zack CJ, et al : National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol 70 : 2953-2960, 2017.
7) Lee JW, et al : Long-term prognosis of isolated significant tricuspid regurgitation. Circ J 74 : 375-380, 2010.
8) Axtell AL, et al : Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J Am Coll Cardiol 74 : 715-725, 2019.
P.266 掲載の参考文献
1) Zoghbi WA, et al : Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound : a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 22 : 975-1014, 2009.
2) Barbetseas J, et al : Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves : an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters. J Am Coll Cardiol. 32 : 1410-1417,1998.
P.277 掲載の参考文献
1) Thuny F, et al : Management of Infective endocarditis : challenges and perspectives. Lancet 379 : 965-675, 2012.
2) Mylonakis E, Calderwood SB : Infective endocarditis in adults. N Eng J Med 345 : 1318-1330, 2001.
3) Durack DT, et al : Utilization of specific echocardiographic findings. Duke Endocarditis Survice. Am J Med 96 : 200-209, 1994.
4) Li JS, et al : Proposed modifications to the Duke criteria for thediagnosis of infective endocarditis. Clin Infect Dis 30 : 633-638, 2000.
5) Anguera I, et al : Periannular Complications in Infective Endocarditis Involving Prosthetic Aortic Valves. Am J Cardiol 98 : 1261-1268, 2006.
6) 日本循環器学会 : 感染性心内膜炎の予防と治療に関するガイドライン (2017年度改訂版), 2017. (http://www.j-circ.or.jp/guideline/pdf/JCS2017_nakatani_h.pdf)
7) Habib G : 2015 ESC Guidelines for the management of infective endocarditis : the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) endorsed by : European Association for Cardio-Thoracic Society (EACTS), the European Association pf Nuclear Medicine (EANM). Eur Heart J 36 : 3075-3128, 2015.
8) Lalani T, et al : International Collaboration on Endocarditis-Prospective Cohort Study Investigators. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 173 : 1495-1504, 2013.
9) Kiefer T, et al : Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306 : 2239-2247, 2011.
10) Thuny F, et al : The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis : a propensity analysis. Eur Heart J 32 : 2027-2033, 2011.
11) Leone S, et al : Epidemiology, characteristics, and outcome of infective endocarditis in Italy : the Italian Study on Endocarditis. Infection 40 : 527-535, 2012.
12) Lopez J, et al : Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J 34 : 1749-1754, 2013.
13) Vilacosta I, et al : Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 39 : 1489-1495, 2002.
14) Garcia-Cabrera E, et al : Group for the Study of Cardiovascular Infections of the Andalusian Society of Infectious Diseases. Neurological complications of infective endocarditis : risk factors, outcome, and impact of cardiac surgery : a multicenter observational study. Circulation 127 : 2272-2284, 2013.
15) Eishi K, et al : Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg 110 : 1745-1755, 1995.
16) Ruttmann E, et al : Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke 37 : 2094-2099, 2006.
17) Ting W, et al : Valve replacement in patients with endocarditis and cerebral septic emboli. Ann Thorac Surg 51 : 18-21 ; discussion 22, 1991.
18) Misfeld M, et al : Surgery for infective endocarditis complicated by cerebral embolism : a consecutive series of 375patients. J Thorac Cardiovasc Surg 147 : 1837-1844, 2014.
19) Sorabella RA, et al : Early Operation for Endocarditis Complicated by Preoperative Cerebral Emboli Is Not Associated With Worsened Outcomes. Ann Thorac Surg 100 : 501-508, 2015.
20) Kang DH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366 : 2466-2473, 2012.
21) Shang E, et al : Mitral valve infective endocarditis : benefit of early operation and aggressive use of repair. Ann Thorac Surg 87 : 1728-1733, 2009.
22) Fukuda W, et al : Management of infective endocarditis with cerebral complications. Ann Thorac Cardiovasc Surg 20 : 229-236, 2014.
23) Nakamura H, et al : Treatment Strategy for Infectious Intracranial Aneurysms in the Era of Interventional Neuroradiology. JNET 11 : 497-503, 2017.

最近チェックした商品履歴

Loading...